Suchergebnisse - "Coates, Laura C"

PubPharm (387)

1

Qualitative interview study of rheumatology patients' experiences of COVID-19 shielding to explore the physical and psychological impact and identify associated support needs

enthalten in: BMJ open | 2024

von Silverthorne, C. | Jones, B. | Brooke, M. | +5

2

Patient-Initiated Follow-Up

enthalten in: The Journal of rheumatology | 2024

von Alveyn, E. | Galloway, J. | Coates, L.

3

The comparative performance of three screening questionnaires for psoriatic arthritis in a primary care surveillance study

enthalten in: Rheumatology (Oxford, England) | 2024

von Helliwell, P. | Coates, L. | Ransom, M. | +15

4

Comment on : MRI characteristics in patients with psoriatic arthritis and axial manifestations from the MAXIMISE cohort: Reply

enthalten in: Rheumatology (Oxford, England) | 2024

von Baraliakos, X. | Pournara, E. | Coates, L. | +5

5

Improvements in patient-reported outcomes after treatment with deucravacitinib in patients with psoriatic arthritis : results from a randomized phase 2 trial

enthalten in: Arthritis care & research | 2024

von Strand, V. | Gossec, L. | Coates, L. | +9

6

Guselkumab provides durable improvement across psoriatic arthritis disease domains : post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study

enthalten in: RMD open | 2024

von Coates, L. | Gossec, L. | Zimmermann, M. | +8

7

Enhancing current guidance for psoriatic arthritis and its comorbidities : recommendations from an expert consensus panel

enthalten in: Rheumatology (Oxford, England) | 2024

von Coates, L. | Bukhari, M. | Chan, A. | +9

8

Patient clusters identified by machine learning from a pooled analysis of the clinical development programme of secukinumab in psoriatic arthritis, ankylosing spondylitis and psoriatic arthritis with axial manifestations

enthalten in: Clinical and experimental rheumatology | 2024

von Baraliakos, X. | Pournara, E. | Coates, L. | +3

9

Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors : 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL

enthalten in: RMD open | 2024

von Coates, L. | Landewé, R. | McInnes, I. | +15

10

Ethnicity data resource in population-wide health records : completeness, coverage and granularity of diversity

enthalten in: Scientific data | 2024

von Pineda-Moncusí, M. | Allery, F. | Delmestri, A. | +18

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[39]